ADAR1 Capital Management, LLC

Position in GERN — Geron Corp

CIK 1940272 AUSTIN, TX

Position in GERN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$647,445

+$349,445 QoQ

Shares Held

505,817

+152.9% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#68

of 258 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. GERN ranks #139 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,804,703	$240,494,721
2	PTGX	Protagonist Therapeutics, Inc	960,863	$117,782,586
3	ROIV	Roivant Sciences Ltd.	3,157,008	$111,726,513
4	IMVT	Immunovant, Inc.	2,330,716	$89,802,487
5	ZLAB	Zai Lab Ltd	3,369,034	$64,011,646
6	AGIO	Agios Pharmaceuticals, Inc.	1,288,053	$47,799,646
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,222,080	$45,730,233
8	CYTK	Cytokinetics Inc	457,907	$39,009,097

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$647,445	505,817	+152.9%	Shares	Sole	2026-08-14
2026-03-31	$298,000	200,000	-40.5%	Shares	Sole	2026-05-18
2025-12-31	$443,752	336,176	-26.3%	Shares	Sole	2026-02-18
2025-09-30	$624,961	456,176	+3.4%	Shares	Sole	2025-11-14
2025-06-30	$622,058	441,176	+65.7%	Shares	Sole	2025-08-14
2025-03-31	$423,219	266,176	-21.2%	Shares	Sole	2025-05-15
2024-12-31	$1,195,373	337,676	-39.4%	Shares	Sole	2025-02-13
2024-09-30	$2,529,501	557,159	+519.1%	Shares	Sole	2024-11-14
2024-06-30	$381,600	90,000	+6849.8%	Shares	Sole	2024-08-13
2024-03-31	$4,273	1,295	-92.5%	Shares	Sole	2024-05-15
2023-12-31	$36,492	17,295	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.